3398-11-6 Usage
Uses
Used in Pharmaceutical Industry:
Estra-1,3,5(10)-triene-3,7,17-triol is used as a pharmaceutical agent for its potential therapeutic effects. It has been found to possess estrogenic activity, making it a candidate for hormone replacement therapy and treatment of various conditions related to hormonal imbalances.
Used in Cosmetic Industry:
Estra-1,3,5(10)-triene-3,7,17-triol is used as an ingredient in cosmetic products for its potential anti-aging and skin rejuvenation properties. Its estrogenic activity may contribute to improved skin elasticity, hydration, and overall skin health.
Used in Research Applications:
Estra-1,3,5(10)-triene-3,7,17-triol is used as a research tool in the study of steroidal compounds, their synthesis, and biological effects. It can be employed to investigate the mechanisms of action, metabolism, and potential applications of related compounds in various fields of research.
Check Digit Verification of cas no
The CAS Registry Mumber 3398-11-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,3,9 and 8 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 3398-11:
(6*3)+(5*3)+(4*9)+(3*8)+(2*1)+(1*1)=96
96 % 10 = 6
So 3398-11-6 is a valid CAS Registry Number.
InChI:InChI=1/C18H24O3/c1-18-7-6-13-12-3-2-11(19)8-10(12)9-15(20)17(13)14(18)4-5-16(18)21/h2-3,8,13-17,19-21H,4-7,9H2,1H3/t13-,14+,15-,16+,17-,18+/m1/s1
3398-11-6Relevant academic research and scientific papers
Cytoprotective steroids (II)
-
, (2008/06/13)
A method is provided for treating a patient in need of therapy for acute neuronal degeneration due to metabolic compromise of central or peripheral nervous system cells comprising administering to that patient a therapeutically effective amount of a 7α-hydroxy substituted steroid selected from 7α-hydroxy-derivatives of estradiols, dehydroepiandrosterones and pregnenolones, and metabolic precursors thereof. Use of such compounds for manufacture of medicaments and neuroprotective compositions are also provided.
